nimotop 30mg 30mg oral solid ordinary film-coated tablets
bayer pharma ag - nimodipine - oral solid ordinary film-coated tablets - 30mg
nimotop 0.2mg/ml parenteral ordinary i v vials
bayer pharma ag - nimodipine - parenteral ordinary i v vials - 0.2mg/ml
nimotop iv solution for infusion
bayer pharma ag bayer pharma ag 51368 leverkusen, germany - nimodipine - solution for infusion - 1 bottle of nimotop solution for infusion 10 mg - calcium channel blockers - selective calcium
nimotop 10mg-50ml infusion solution for infusion
bayer pharma ag, germany - nimodipine - solution for infusion - 0.2 mg/ml
nimotop infusion solution 0.02% 50ml
bayer co. (malaysia) sdn. bhd. - nimodipine -
nimotop 30mg tab tablet
bayer ag, germany - nimodipine - tablet - 30 mg
aspen nimodipine iv infusion (parenteral)
litha pharma (pty) ltd - infusion (parenteral) - see ingredients - each 50,0 ml solution contains nimodipine 10,0 mg
depalept 500 enteric coated tablets
cts chemical industries ltd, israel - valproic acid as sodium - tablets enteric coated - valproic acid as sodium 500 mg - valproic acid - valproic acid - generalized or partial epilepsy, secondary generalized epilepsy, mixed forms of epilepsy.
depalept syrup
cts chemical industries ltd, israel - valproic acid as sodium - syrup - valproic acid as sodium 40 mg/ml ml - valproic acid - valproic acid - generalized or partial epilepsy secondary generalized epilepsy and mixed forms of epilepsy.
depalept 200 mg
cts chemical industries ltd, israel - valproic acid as sodium - tablets enteric coated - valproic acid as sodium 200 mg - valproic acid - valproic acid - anti-epileptic.